5 hours ago
1
cagkansayin/iStock via Getty Images
- Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) said that the UK health authority has approved its experimental therapy, elinzanetant, branded as Lynkuet, for treating moderate to severe hot flashes related to menopause.
- The marketing authorization in the UK is the first approval worldwide for
English (US) ·